May 15, 2017 / 12:12 PM / 2 months ago

BRIEF-Bellerophon Q1 loss per share $0.60

1 Min Read

May 15 (Reuters) - Bellerophon Therapeutics Inc:

* Bellerophon reports first quarter 2017 financial results and provides business update

* Q1 loss per share $0.60

* Bellerophon Therapeutics - believes that as of march 31, 2017, it has sufficient funds to satisfy its operating cash needs for at least next 12 months

* Bellerophon Therapeutics - at March 31, 2017, co had cash and cash equivalents, restricted cash and marketable securities of $17.1 million compared to $20.5 million at December 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below